Literature DB >> 31299414

Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children.

Victor V S Albuquerque1, Nathella Pavan Kumar2, Kiyoshi F Fukutani3, Beatriz Vasconcelos1, Maria B Arriaga3, Paulo S Silveira-Mattos3, Subash Babu4, Bruno B Andrade5.   

Abstract

The immune profile associated with distinct clinical forms of tuberculosis (TB) has been extensively described for adult populations. Nevertheless, studies describing immune determinants of pulmonary or extrapulmonary TB (PTB or EPTB, respectively) in children are scarce. Here, we retrospectively assessed plasma levels of several mediators of inflammation in age and sex-matched children from South India presenting with PTB (n = 14) or EPTB (n = 22) as well as uninfected healthy controls (n = 19) to identify biomarkers that could accurately distinguish different TB clinical forms. Furthermore, we performed exploratory analyses testing the influence of sex on the systemic inflammatory profile. The analyses identified a biosignature of 10 biomarkers capable of distinguishing the three clinical groups simultaneously. Machine-learning decision trees indicated that C-reactive protein (CRP), matrix metalloproteinase (MMP)-7 and lipopolysaccharide-binding protein (LBP) were the markers that, when combined, displayed the highest accuracy in identifying the clinical groups. Additional exploratory analyses suggested that the disease signatures were highly influenced by sex. Therefore, sex differentially impacted status of systemic inflammation, immune activation and tissue remodeling in children with distinct clinical forms of TB. Regardless of such nuances related to biological sex, MMP-7, CRP and LBP were strong discriminators of active TB and thus could be considered as biomarkers useful in discrimination different TB clinical forms. These observations have implications on our understanding of the immunopathology of both clinical forms of TB in pediatric patients. If validated by other studies in the future, the combination of identified biomarkers may help development of point-of-care diagnostic or prognostic tools.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Children; Diagnosis; Inflammation; Tuberculosis

Year:  2019        PMID: 31299414     DOI: 10.1016/j.cyto.2019.154773

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  The Role of C-Reactive Protein as a Triage Tool for Pulmonary Tuberculosis in Children.

Authors:  Devan Jaganath; Tania F Reza; Peter Wambi; Jascent Nakafeero; Emma Kiconco; Gertrude Nanyonga; Ernest A Oumo; Moses C Nsereko; Moorine P Sekadde; Mary G Nabukenya-Mudiope; Midori Kato-Maeda; Alfred Andama; Christina Yoon; Swomitra Mohanty; Eric Wobudeya; Adithya Cattamanchi
Journal:  J Pediatric Infect Dis Soc       Date:  2022-07-21       Impact factor: 5.235

2.  Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis.

Authors:  Deivide Oliveira-de-Souza; Caian L Vinhaes; María B Arriaga; Nathella Pavan Kumar; Artur T L Queiroz; Kiyoshi F Fukutani; Subash Babu; Bruno B Andrade
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

3.  Antibody-Secreting Cells To Diagnose Mycobacterium tuberculosis Infection in Children in Pakistan.

Authors:  Najeeha Talat Iqbal; Kumail Ahmed; Farah N Qamar; Fariha Shaheen; Aisha Mehnaz; Fehmina Arif; Amna Afzal Saeed; Aneeq Muhammad Yousuf; Syeda Fatima Raza; Shazia Sultana; Shahida Mumtaz Qureshi; Shakil Ahmad Siddiqi; Eric Houpt; Tania Thomas
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

Review 4.  Heme Oxygenase-1 as a Pharmacological Target for Host-Directed Therapy to Limit Tuberculosis Associated Immunopathology.

Authors:  Krishna C Chinta; Hayden T Pacl; Anupam Agarwal; Adrie J C Steyn
Journal:  Antioxidants (Basel)       Date:  2021-01-26

5.  Screening tests for active pulmonary tuberculosis in children.

Authors:  Bryan Vonasek; Tara Ness; Yemisi Takwoingi; Alexander W Kay; Susanna S van Wyk; Lara Ouellette; Ben J Marais; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2021-06-28

Review 6.  Towards Accurate Point-of-Care Tests for Tuberculosis in Children.

Authors:  Nina Vaezipour; Nora Fritschi; Noé Brasier; Sabine Bélard; José Domínguez; Marc Tebruegge; Damien Portevin; Nicole Ritz
Journal:  Pathogens       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.